Net sales and ARR declined year-over-year amid high churn and a major contract loss, but profitability improved with a 4.8% adjusted EBITDA less Capex margin. New product launches and leadership changes aim to support long-term growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.